Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience [PDF]
, 2015 Apostolia Tsimberidou +15 more
core +1 more source
THE INHIBITORY EFFECT OF COPPER-CHELATOR, TRIENTINE, ON LIVER TUMOR GROWTH AND ON HEPATOCARCINOGENESIS BY ANGIOGENESIS SUPPRESSION [PDF]
, 2004 Angiogenesis is now recognized to play a pivotal role in tumor development, and even in the process of carcinogenesis. Trientine dihydrochloride (trientine) is used in clinical practice as a copper (Cu)-chelating agent.
吉井, 純一
core
ヘンイ SOD1 二 ヨル ドウドクセイ ノ ケンショウ カゾクセイ キンイシュクセイ ソクサク コウカショウ モデル マウス ヲ モチイタ ケンキュウ [PDF]
Nagano, Seiichi +2 more
core +1 more source
A Copper Binding Site within the Pathological Conformer Epitope of Mutant SOD1 [PDF]
, 2011 Ashley I. Bush
core +1 more source
The Trientine Crisis in Canada: A Call to Advocacy
Canadian Journal of Gastroenterology and Hepatology, 2014 Natasha Chandok, Eve A Roberts
doaj +1 more source
Exploratory longitudinal cohort study of modest bilirubin-driven biochemical liver alterations after SARS-CoV-2 infection in a selected subgroup of patients with Wilson's disease and liver cirrhosis. [PDF]
BMC GastroenterolKöhrer S +7 more
europepmc +1 more source
Wilson protein expression, copper excretion and sweat production in sweat glands of Wilson disease patients and controls [PDF]
core +1 more source
Iron and Copper Homeostasis in Cardiometabolic Disease: Therapeutic Potential of Chelators. [PDF]
Pharmaceuticals (Basel)Lachowicz JI, Gać P.
europepmc +1 more source